Our purpose is to fuel the growth of the cannabis industry and eliminate barriers for success. We see a world that shifts from cannabis prohibition to regulation so that all patients and adults have access to safe, regulated cannabis.
AmeriCann, Inc. is a registered, audited, publicly traded (Stock Symbol: ACAN), and fully reporting company with corporate offices in Denver and Boston. The company is focused on bringing sustainability and efficiency to the design, construction and oversight of highly productive, energy efficient greenhouse cannabis cultivation and processing facilities.
Our Flagship Project, the Massachusetts Cannabis Center, is permitted for 987,000 square feet and is currently under construction. Building 1 is scheduled for delivery in August of 2019 and is 100% leased to AmeriCann’s JV Partner for 15-years.
Attorneys: Hart & Hart, LLP, Denver, Colorado. Auditors: Malone Bailey, Houston, TX Stock Transfer Agent: Island Stock Transfer Business: AmeriCann, Inc. (“Company”) designs, develops and owns advanced cannabis facilities to produce the best possible cannabis in the most efficient manner utilizing advanced, sustainable practices. AmeriCann does not currently cultivate, process or distribute cannabis, but partners with local business to serve marijuana patients and consumers in their communities.
For investor and stockholder inquiries or requests for information please email: email@example.com